An altered immune response to Epstein-Barr virus in multiple sclerosis -: A prospective study

被引:214
作者
Sundström, P
Juto, P
Wadell, G
Hallmans, G
Svenningsson, A
Nyström, L
Dillner, J
Forsgren, L
机构
[1] Univ Umea Hosp, Dept Neurol, Umea, Sweden
[2] Univ Umea Hosp, Dept Virol, Umea, Sweden
[3] Umea Univ, Dept Publ Hlth & Clin Med, S-90187 Umea, Sweden
[4] Lund Univ, Malmo Univ Hosp, Dept Med Microbiol, S-22100 Lund, Sweden
关键词
D O I
10.1212/01.WNL.0000130496.51156.D7
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To investigate the association between human herpesviruses and multiple sclerosis ( MS), as well as between measles virus and MS. Methods: The authors identified prospectively collected serum samples from 73 MS cases and retrospective sera from 161 MS cases in two population-based serum bank registers. Analyses of IgG antibody responses in cases and matched referents were performed for Epstein-Barr virus (EBV [EBNA-1 and VCA]), human herpesvirus 6 (HHV-6), herpes simplex virus (HSV), varicella zoster virus (VZV), and measles. Results: All cases showed signs of past EBV infection. High activity to EBNA-1 and HHV-6 significantly ( borderline significance for HHV-6) increased the risk for MS in prospective sera. A discrepancy between activities to EBNA-1 and VCA was striking in MS samples collected less than 5 years before relapsing-remitting MS onset, where high activity to EBNA-1 significantly increased, and high VCA activity significantly decreased the risk for MS. There was no support for major causal roles for HSV, VZV, or measles. Conclusion: Individuals who will develop MS exhibit an altered immune response against the EBV virus characterized by a high IgG activity to EBNA-1 in the absence of high activity to VCA, this being most pronounced in the 5-year period preceding MS onset.
引用
收藏
页码:2277 / 2282
页数:6
相关论文
共 34 条
  • [1] ADAMS JM, 1962, P SOC EXP BIOL MED, V111, P562, DOI 10.3181/00379727-111-27855
  • [2] Epstein-Barr virus and multiple sclerosis
    Ascherio, A
    Munch, M
    [J]. EPIDEMIOLOGY, 2000, 11 (02) : 220 - 224
  • [3] Epstein-Barr virus antibodies and risk of multiple sclerosis -: A prospective study
    Ascherio, A
    Munger, KL
    Lennette, ET
    Spiegelman, D
    Hernán, MA
    Olek, MJ
    Hankinson, SE
    Hunter, DJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (24): : 3083 - 3088
  • [4] Blaschke S, 2000, J RHEUMATOL, V27, P866
  • [5] DEMYELINATING DISEASE AFTER NEUROLOGICALLY COMPLICATED PRIMARY EPSTEIN-BARR-VIRUS INFECTION
    BRAY, PF
    CULP, KW
    MCFARLIN, DE
    PANITCH, HS
    TORKELSON, RD
    SCHLIGHT, JP
    [J]. NEUROLOGY, 1992, 42 (02) : 278 - 282
  • [6] ANTIBODIES AGAINST EPSTEIN-BARR NUCLEAR ANTIGEN (EBNA) IN MULTIPLE-SCLEROSIS CSF, AND 2 PENTAPEPTIDE SEQUENCE IDENTITIES BETWEEN EBNA AND MYELIN BASIC-PROTEIN
    BRAY, PF
    LUKA, J
    BRAY, PF
    CULP, KW
    SCHLIGHT, JP
    [J]. NEUROLOGY, 1992, 42 (09) : 1798 - 1804
  • [7] Human herpesvirus 6: An emerging pathogen
    Campadelli-Fiume, G
    Mirandola, P
    Menotti, L
    [J]. EMERGING INFECTIOUS DISEASES, 1999, 5 (03) : 353 - 366
  • [8] Human herpesvirus 6 in the pathogenesis of multiple sclerosis
    Enbom, M
    [J]. APMIS, 2001, 109 (06) : 401 - 411
  • [9] EPSTEIN MA, 1999, ENCY LIFE SCI
  • [10] Association of chronic progressive neurological disease and ubiquitous viral agents: lessons from human herpesvirus 6 and multiple sclerosis
    Fogdell-Hahn, A
    Soldan, SS
    Jacobson, S
    [J]. MOLECULAR PSYCHIATRY, 2002, 7 (Suppl 2) : S29 - S31